Gadolinium and Basal Ganglia. An experience with Gadoxetate disodium
The authors have followed-up patients who received recurrent injections of Gadoxetate disodium. Iterative measurements of signal intensity in basal ganglia did not reveal any changes over time.
- Gadolinium may deposit in the human brain after multiple GBCA administrations
- Gadolinium deposition is associated with increased T1W signal intensity
- Increase in signal intensity is most apparent within the DN and GP
- Multiple administrations of gadoxetate disodium do not increase T1W signal
Authors: Giorgio Conte, Lorenzo Preda, Emilia Cocorocchio et al.